This T-Mobile Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• B of A Securities analyst Tazeen Ahmad downgraded the rating for Sutro Biopharma, Inc. STRO from Buy to Underperform and lowered the price target from $11 to $1. Sutro Biopharma shares closed at $1.25 on Thursday. See how other analysts view this stock.
• Jefferies analyst Matthew Hurwit downgraded Advanced Flower Capital Inc. AFCG from Buy to Hold and slashed the price target from $10 to $7. Advanced Flower Capital shares closed at $6.76 on Thursday. See how other analysts view this stock.
• Stifel analyst Chris O’Cull downgraded Xponential Fitness, Inc. XPOF from Buy to Hold and lowered the price target from $20 to $12. Xponential Fitness shares closed at $12.12 on Thursday. See how other analysts view this stock.
• Citigroup analyst Michael Rollins downgraded the rating for T-Mobile US, Inc. TMUS from Buy to Neutral and announced a $268 price target. T-Mobile US shares closed at $259.10 on Thursday. See how other analysts view this stock.

Considering buying STRO stock? Here’s what analysts think:

Read This Next:

• Top 3 Industrials Stocks That May Rocket Higher This Month